Novel Molecular Consortia of Cannabidiol with Nonsteroidal Anti-Inflammatory Drugs Inhibit Emerging Coronaviruses’ Entry

The COVID-19 pandemic provoked a global health crisis and highlighted the need for new therapeutic strategies. In this study, we explore the potential of the molecular consortia of cannabidiol (CBD) and non-steroidal anti-inflammatory drugs (NSAIDs) as novel antiviral dual-target agents against SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawełczyk, Anna, Nowak, Rafał, Gazecka, Monika, Jelińska, Anna, Zaprutko, Lucjusz, Zmora, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383849/
https://www.ncbi.nlm.nih.gov/pubmed/37513798
http://dx.doi.org/10.3390/pathogens12070951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383849/
https://www.ncbi.nlm.nih.gov/pubmed/37513798
http://dx.doi.org/10.3390/pathogens12070951

Ejemplares similares